Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Blocking GPR91 can help prevent and reverse hair loss in androgenetic alopecia.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

A multidisciplinary approach is key to delaying aging and preventing age-related diseases.

Keratin mutations cause skin diseases and could lead to new treatments.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Advanced human skin models improve drug development and could replace animal testing.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.